Tumor Necrosis Factor as a Pharmacological Target

ISSN： 1073-6085

Source： Molecular Biotechnology, Vol.31, Iss.3, 2005-11, pp. : 239-244

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mutational analysis of human tumor necrosis factor-α

By Shin Hang-Cheol

Biotechnology Letters, Vol. 27, Iss. 2, 2005-01 ,pp. : 107-112

Springer Publishing Company

Access to resources Recommend Favorite

Stability of tumor necrosis factor-α during ion exchange chromatography

By Li M. Wang Y. Li W. Su Z.

Biotechnology Letters, Vol. 25, Iss. 11, 2003-06 ,pp. : 905-908

Springer Publishing Company

Access to resources Recommend Favorite

Polyethylene glycol improves the purification of recombinant human tumor necrosis factor during ion exchange chromatography

By Feng X-L.

Biotechnology Techniques, Vol. 12, Iss. 4, 1998-04 ,pp. : 289-293

Springer Publishing Company

Access to resources Recommend Favorite

Biological and physicochemical evaluation of the conformational stability of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

By Youn Yu Shin Min Chae Su Jin Cheng-Hao Kim Tae Lee Kang

Biotechnology Letters, Vol. 29, Iss. 5, 2007-05 ,pp. : 713-721

Springer Publishing Company

Access to resources Recommend Favorite

Impact of intraoperative blood salvage on monocyte subsets alteration and intracellular tumor necrosis factor‐α production

Journal Of Biomedical Materials Research. Part A, Vol. 106, Iss. 3, 2018-03 ,pp. : 815-821

John Wiley & Sons Inc

Access to resources Recommend Favorite